The author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.
Andrew Fussell
Advertisement
Articles by Andrew Fussell
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Rare Disease Framework Puts CMC Review in Scope
2
Clinical Trial Delays: FDA’s Expedited IND Pilot vs China’s 818 Decree
3
PharmTech AI Pulse Check: AI Watermark Vulnerability
4
Manufacturing Intelligence: What FDA's Real-World Use Case Database Means for CMC
5